Literature DB >> 11207374

The roles of iron in health and disease.

P T Lieu1, M Heiskala, P A Peterson, Y Yang.   

Abstract

Iron is vital for almost all living organisms by participating in a wide variety of metabolic processes, including oxygen transport, DNA synthesis, and electron transport. However, iron concentrations in body tissues must be tightly regulated because excessive iron leads to tissue damage, as a result of formation of free radicals. Disorders of iron metabolism are among the most common diseases of humans and encompass a broad spectrum of diseases with diverse clinical manifestations, ranging from anemia to iron overload and, possibly, to neurodegenerative diseases. The molecular understanding of iron regulation in the body is critical in identifying the underlying causes for each disease and in providing proper diagnosis and treatments. Recent advances in genetics, molecular biology and biochemistry of iron metabolism have assisted in elucidating the molecular mechanisms of iron homeostasis. The coordinate control of iron uptake and storage is tightly regulated by the feedback system of iron responsive element-containing gene products and iron regulatory proteins that modulate the expression levels of the genes involved in iron metabolism. Recent identification and characterization of the hemochromatosis protein HFE, the iron importer Nramp2, the iron exporter ferroportin1, and the second transferrin-binding and -transport protein transferrin receptor 2, have demonstrated their important roles in maintaining body's iron homeostasis. Functional studies of these gene products have expanded our knowledge at the molecular level about the pathways of iron metabolism and have provided valuable insight into the defects of iron metabolism disorders. In addition, a variety of animal models have implemented the identification of many genetic defects that lead to abnormal iron homeostasis and have provided crucial clinical information about the pathophysiology of iron disorders. In this review, we discuss the latest progress in studies of iron metabolism and our current understanding of the molecular mechanisms of iron absorption, transport, utilization, and storage. Finally, we will discuss the clinical presentations of iron metabolism disorders, including secondary iron disorders that are either associated with or the result of abnormal iron accumulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207374     DOI: 10.1016/s0098-2997(00)00006-6

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  122 in total

1.  C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.

Authors:  Michele F Eisenga; Marco van Londen; David E Leaf; Ilja M Nolte; Gerjan Navis; Stephan J L Bakker; Martin H de Borst; Carlo A J M Gaillard
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

2.  Biocorrosion properties and blood and cell compatibility of pure iron as a biodegradable biomaterial.

Authors:  Erlin Zhang; Haiyan Chen; Feng Shen
Journal:  J Mater Sci Mater Med       Date:  2010-04-16       Impact factor: 3.896

Review 3.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

4.  The design, synthesis, and evaluation of organ-specific iron chelators.

Authors:  Raymond J Bergeron; Jan Wiegand; James S McManis; Neelam Bharti
Journal:  J Med Chem       Date:  2006-11-30       Impact factor: 7.446

5.  Enterobactin, an iron chelating bacterial siderophore, arrests cancer cell proliferation.

Authors:  Piu Saha; Beng San Yeoh; Xia Xiao; Rachel M Golonka; Sivarajan Kumarasamy; Matam Vijay-Kumar
Journal:  Biochem Pharmacol       Date:  2019-06-19       Impact factor: 5.858

6.  Design, Synthesis, and Biological Evaluation of Polyaminocarboxylate Ligand-Based Theranostic Conjugates for Antibody-Targeted Cancer Therapy and Near-Infrared Optical Imaging.

Authors:  Siyuan Ren; Xiang Sun; Haixing Wang; Trung Hai Nguyen; Negar Sadeghipour; Xiaochun Xu; Chi Soo Kang; Yujie Liu; Hua Xu; Ningjie Wu; Yanda Chen; Kenneth Tichauer; David D L Minh; Hyun-Soon Chong
Journal:  ChemMedChem       Date:  2018-11-26       Impact factor: 3.466

7.  Retrospective comparison of gradient recalled echo R2* and spin-echo R2 magnetic resonance analysis methods for estimating liver iron content in children and adolescents.

Authors:  Suraj D Serai; Robert J Fleck; Charles T Quinn; Bin Zhang; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2015-05-26

8.  Kidney stone analysis techniques and the role of major and trace elements on their pathogenesis: a review.

Authors:  Vivek K Singh; Pradeep K Rai
Journal:  Biophys Rev       Date:  2014-07-31

Review 9.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

Review 10.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.